Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKainos Group Regulatory News (KNOS)

Share Price Information for Kainos Group (KNOS)

Share Price is delayed by 15 minutes
Get Live Data
811.00    -22.00 (-2.64%)
Bid:
808.50
Ask:
814.00
Spread: 5.50 (0.68%)
Market Cap: £934.06m
KNOS Live PriceLast checked at - London Stock Exchange

Intraday Kainos Group Share Chart

Trading Update

6 Sep 2016 07:00

RNS Number : 0050J
Kainos Group plc
06 September 2016
 

 

ANNOUNCEMENT

6 September 2016

 

Kainos Group plc

("Kainos" or "the Group")

Trading Update

 

- Group maintains guidance for current year -

 

Kainos Group plc (KNOS), a leading UK-based provider of IT, consulting and software solutions, today issues a trading update for the period from 1 April 2016 to 31 August 2016.

 

In the Digital Services division, the Group is experiencing good growth in the public sector. Demand from central and regional government clients continues to strengthen, with notable new contract wins at the National Offender Management Service and the Home Office.

 

Demand for WorkSmart services is strong in the UK and mainland Europe, where the Group has added a number of new enterprise clients, including Tullett Prebon Group Limited. Take-up of the Group's SaaS-based automated testing product, Smart, is solid and the Group continues to invest in both product development and sales and marketing for Smart.

 

The Evolve division continues to make progress with its Integrated Care SaaS platform and has signed a five-year subscription agreement with Hygieia to use Evolve to power its insulin therapy navigation application which aims to help diabetics systematically manage their changing insulin requirements. In the UK, the Evolve for iPad™ offering, which allows clinicians to access electronic patient records on the move, is now in live operation at the South East Coast Ambulance Service. Market conditions in the NHS remain challenging, with limited additional funding to drive demand.

 

Although the outcome of the UK's referendum on Europe ('Brexit') brings with it some uncertainties, the Group continues to see immediate opportunities for growth.

 

Kainos has a robust balance sheet with strong reserves, no debt and strong cash generation, as well as a growing level of recurring revenue. The Group expects results for the full year to be in line with market expectations.

 

 

 

 

-ENDS-

 

For further information, please contact:

 

Kainos via FTI Consulting LLP

Brendan Mooney, Chief Executive Officer

Brian Gannon, SVP Corporate Development

 

Investec Bank plc +44 20 7597 5970

Dominic Emery/Sebastian Lawrence

Patrick Robb/Matt Lewis

 

FTI Consulting LLP +44 20 3727 1000

Matt Dixon/Chris Lane

 

About Kainos

Kainos is a UK-based provider of IT services, consulting and software solutions. It specialises across multiple sectors in the development of digital technology solutions, including software design and agile software development. The Group's Evolve Electronic Medical Records (EMR) product provides a market-leading comprehensive suite of digital services to healthcare providers such as hospitals and community care organisations. Kainos has also developed an automated testing product, Smart, to complement its Workday implementation services.

 

Kainos Group plc (KNOS) is listed on the main market of the London Stock Exchange. At 31 March 2016, it had almost 800 staff working in eight offices in the USA, UK, Ireland, Poland and the Netherlands.

 

For further information please visit the company website: https://www.kainos.com/

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTLAMFTMBBMBFF
Date   Source Headline
24th Nov 20211:11 pmRNSPerson Closely Associated shareholdings
18th Nov 20213:34 pmRNSDirector/PDMR Shareholding
15th Nov 20217:00 amRNSKainos Half-year Report
1st Nov 20215:15 pmRNSTotal Voting Rights
1st Oct 202110:28 amRNSTotal Voting Rights
29th Sep 20213:33 pmRNSHolding(s) in Company
29th Sep 20211:18 pmRNSDirector/PDMR Shareholding
23rd Sep 20215:33 pmRNSAGM Results
23rd Sep 20215:30 pmRNSDirectorate Change
8th Sep 20213:15 pmRNSDirector/PDMR Shareholding
2nd Sep 202110:20 amRNSDirector/PDMR Shareholding
1st Sep 20215:38 pmRNSTotal Voting Rights
1st Sep 20217:00 amRNSAcquisition
1st Sep 20217:00 amRNSTrading Statement
25th Aug 20212:28 pmRNSDirector/PDMR Shareholding
18th Aug 202111:28 amRNSNotice of AGM
12th Aug 20212:05 pmRNSDirector/PDMR Shareholding
10th Aug 202112:41 pmRNSChange of Auditor
2nd Aug 202111:57 amRNSTotal Voting Rights
30th Jul 202112:25 pmRNSAnnual Financial Report
9th Jul 20216:31 pmRNSDirector/PDMR Shareholding
1st Jul 20214:35 pmRNSTotal Voting Rights
29th Jun 20213:58 pmRNSDirector/PDMR Shareholding
1st Jun 20217:00 amRNSAcquisition
24th May 20217:00 amRNSKainos Final Results
21st May 20217:00 amRNSBoard Changes
4th May 202111:49 amRNSTotal Voting Rights
16th Apr 20217:00 amRNSKainos Trading Statement
8th Apr 20213:51 pmRNSHolding(s) in Company
7th Apr 20214:02 pmRNSHolding(s) in Company
1st Apr 20214:23 pmRNSTotal Voting Rights
31st Mar 20214:14 pmRNSHolding(s) in Company
29th Mar 20214:16 pmRNSHolding(s) in Company
23rd Mar 20214:42 pmRNSHolding(s) in Company
11th Mar 20213:50 pmRNSHolding(s) in Company
1st Mar 202111:14 amRNSTotal Voting Rights
18th Feb 20214:26 pmRNSHolding(s) in Company
11th Feb 20213:28 pmRNSHolding(s) in Company
11th Feb 20212:12 pmRNSDirector/PDMR Shareholding
10th Feb 20215:00 pmRNSDirector/PDMR Shareholding
22nd Jan 20217:00 amRNSKainos Trading Update
31st Dec 202010:00 amRNSTotal Voting Rights
21st Dec 20207:00 amRNSKainos Appoint Independent Non-Executive Director
17th Dec 20204:05 pmRNSHolding(s) in Company
16th Dec 20206:06 pmRNSHolding(s) in Company
3rd Dec 20204:49 pmRNSDirector/PDMR Shareholding
1st Dec 20208:16 amRNSTotal Voting Rights
16th Nov 20207:00 amRNSKainos Group plc Interim results
14th Oct 20207:00 amRNSTrading Statement
24th Sep 202010:43 amRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.